PT Ikapharmindo Putramas Tbk (IDX:IKPM)

Revenue by Segment

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Non-Pharma	151.41B	214.47B	241.59B	234.80B	234.05B
Non-Pharma Growth	-29.40%	-11.22%	2.89%	0.32%	-43.09%
Pharmacy	211.65B	197.08B	199.00B	163.37B	146.43B
Pharmacy Growth	7.39%	-0.96%	21.80%	11.57%	-51.48%
Contract Manufacturing	498.89M	510.57M	551.74M	563.52M	439.77M
Contract Manufacturing Growth	-2.29%	-7.46%	-2.09%	28.14%	-84.15%
Total	363.57B	412.07B	441.14B	398.73B	380.92B
Total Growth	-11.77%	-6.59%	10.63%	4.68%	-46.78%

Revenue by Geography

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2021	FY 2020
Period Ending	Dec 31, 2021	Dec 31, 2020
Indonesia	295.40B
Indonesia Growth	-46.78%
outside Indonesia	64.61B
outside Indonesia Growth	-46.78%
Export	20.90B
Export Growth	-46.78%
Total	380.92B
Total Growth	-46.78%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error